The sequence analysis of the BAP1 gene from 12 OMM patients revealed missense mutations in four patients (Chr3: 52407995 C>G, p.S113T; Chr3: 52409864 C>A, p.W5C; Chr3: 52408565 T>A, p.E55V; Chr3: 52402325 C>T, p.R718Q) and this included identifying mutations in both the tumor and the blood samples of one of the patients (Table 1 and Figure 1). This evidence concerns the gene BAP1 and neoplasm.